Intelligence Β· Clinical Development
Pipeline search results
Programs matching βomidβ across our ClinicalTrials.gov index β phase, modality, sponsor, and trial IDs.
Quick answer
Showing 143 pipeline programs matching "omid" from NovaPharmaNews Clinical Development Intelligence β phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Leflunomide 20 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Lenalidomide (CC-5013)
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
Lenalidomide or Pomalidomide
ONCOLYTICS BIOTECH INC
Multiple Myeloma
1 trial -
Sublingual film containing BXCL501 (Dexmedetomidine)
BioXcel Therapeutics
Agitation
1 trial -
Tebipenem Pivoxil Hydrobromide
Spero Therapeutics
Diabetes
1 trial -
Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo
Spero Therapeutics
TQT Study
1 trial -
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
Spero Therapeutics
Healthy Volunteers
1 trial -
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
Spero Therapeutics
Renal Impairment
1 trial -
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Reference
Spero Therapeutics
Healthy Volunteers
1 trial -
pomalidomide
Celgene Europe Limited
Multiple Myeloma in Relapse
1 trial -
0.3% ropivacaine and 50 ΞΌg dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Free Flap Reconstruction
1 trial -
Camrelizumab + chemotherapy+Thalidomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine
The University of Hong Kong
Anxiety, Separation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
Thyroid Diseases
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Function
1 trial -
Dexmedetomidine
Peking University Third Hospital
Aged
1 trial -
Dexmedetomidine
Peking University Third Hospital
Breast Cancer
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lower Limb Fracture
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Post-Surgical Pain
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thoracic Paravertebral Blocks
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs β not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars β improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes β use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.